Cladribine tablets in the new multiple sclerosis era

Multiple sclerosis (MS) is an autoimmune condition characterized by inflammatory demyelination that leads to irreversible neurological damage within the central nervous system (CNS). This review examines the therapeutic potential and clinical efficacy of cladribine tablets (CladT) for treating MS, f...

Full description

Bibliographic Details
Published in:Therapeutic Advances in Neurological Disorders
Main Authors: Fabio Buttari, Ettore Dolcetti, Francesca Romana Rizzo, Caterina Rizzi, Gianluca Lauritano, Angela Borrelli, Federica Azzolini, Roberta Fantozzi, Francesco Assogna, Antonella Conte, Diego Centonze
Format: Article
Language:English
Published: SAGE Publishing 2025-06-01
Online Access:https://doi.org/10.1177/17562864251342855

Internet

https://doi.org/10.1177/17562864251342855

Similar Items